Literatur
Annunziato F, Romagnani S (2009) Heterogeneity of human effector CD4+ T cells. Arthritis Res Ther 11:257
Skapenko A, Leipe J, Lipsky PE, Schulze-Koops H (2005) The role of the T cell in autoimmune inflammation. Arthritis Res Ther 7(Suppl 2):S4–S14
Stronkhorst A et al (1997) CD4 antibody treatment in patients with active Crohn’s disease: a phase 1 dose finding study. Gut 40:320–327
Rowland-Jones SL (2003) Timeline: AIDS pathogenesis: what have two decades of HIV research taught us? Nat Rev Immunol 3:343–348
MacLeod MK, Clambey ET, Kappler JW, Marrack P (2009) CD4 memory T cells: what are they and what can they do? Semin Immunol 21:53–61
Haftmann C et al (2015) miR-148a is upregulated by Twist1 and T‑bet and promotes Th1-cell survival by regulating the proapoptotic gene Bim. Eur J Immunol 45:1192–1205
Cosmi L, Maggi L, Santarlasci V, Liotta F, Annunziato F (2014) T helper cells plasticity in inflammation. Cytometry A 85:36–42
Powrie F, Leach MW, Mauze S, Caddle LB, Coffman RL (1993) Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B‑17 scid mice. Int Immunol 5:1461–1471
Maschmeyer P et al (2017) Selective targeting of pro-inflammatory Th1 cells by microRNA-148a-specific antagomirs in vivo. J Autoimmun: 89:41–52. https://doi.org/10.1016/j.jaut.2017.11.005
Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH (2000) A novel transcription factor, T‑bet, directs Th1 lineage commitment. Cell 100:655–669
Krutzfeldt J et al (2005) Silencing of microRNAs in vivo with ‘antagomirs. Nature 438:685–689
Li Z, Rana TM (2014) Therapeutic targeting of microRNAs: current status and future challenges. Nat Rev Drug Discov 13:622–638
Ostanin DV et al (2009) T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade. Am J Physiol Gastrointest Liver Physiol 296:G135–146
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
P. Maschmeyer und M.-F. Mashreghi geben an, dass kein Interessenkonflikt besteht.
Alle nationalen Richtlinien zur Haltung und zum Umgang mit Labortieren wurden eingehalten, und die notwendigen Zustimmungen der zuständigen Behörden liegen vor.
Additional information
Redaktion
A. Radbruch, Berlin
R.E. Schmidt, Hannover
R. Straub, Regensburg
U. Wagner, Leipzig
Rights and permissions
About this article
Cite this article
Maschmeyer, P., Mashreghi, MF. Selektive Depletion proinflammatorischer Typ-1-T-Helfer-Zellen mit mikroRNA-148a-spezifischen Antagomirs. Z Rheumatol 77, 508–510 (2018). https://doi.org/10.1007/s00393-018-0477-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00393-018-0477-7